Dania brings to Rheos more than 15 years’ experience building and leading teams of scientists in drug discovery and early development. Dr. Rabah served as the Head of the Drug Discovery Incubator, Research and Early Development at Biogen. She and her team created a robust and innovative pipeline, advanced programs across multiple therapeutic areas and treatment modalities, advanced therapeutic area strategies to support development, and implemented research operating model improvements to support a biology and target driven development approach. She also brings extensive experience in immunology drug development, having advanced candidates from program initiation through Phase 2 clinical proof of concept.
Dania earned her Ph.D. in Microbiology and Immunology from Virginia Commonwealth University/Medical College of Virginia, and an M.S. in Human Morphology and Immunology and a B.S. in Biology both from the American University of Beirut. She completed her post-doctoral training in Immunology at Harvard Medical School.